This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08244/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08244/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB08244/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08244/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08244/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08244
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08244 n14:DB08244
dcterms:title
(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE
adms:identifier
n6:DB08244 n7:N4T n8:4810325 n11:6102824 n13:99444715
n3:IUPAC-Name
n4:271B4540-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4546-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4545-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4542-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4543-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4544-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B453E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B453C-363D-11E5-9242-09173F13E4C5 n4:271B453F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B453D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B454C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B454D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4547-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4548-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B454A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4549-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B454B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4551-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4553-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4554-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4550-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B454F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4552-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4541-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B454E-363D-11E5-9242-09173F13E4C5